UC San Diego School of Medicine receives $6.1M to launch a new research center studying the effects of maternal antibiotic use on breast milk and infant health. The center is funded by National Institutes of Health, as part of their new Maternal and Pediatric Precision in Therapeutics (MPRINT) Hub.
UC San Diego researchers discovered that immunotoxins targeting the protein mesothelin prevent liver cells from producing collagen, a precursor to fibrosis and cirrhosis, in mouse models of human disease. Click here to view original post… […]
In classic UC San Diego fashion, an overheard conversation at a campus coffee cart has turned into an interdisciplinary project that’s making computing-intensive coursework more exciting while saving well over $… […]
CARI Therapeutics has received additional funding from the National Institute of Drug Abuse to refine their tiny implantable biosensor that could help combat the deadly and destructive opioid crisis in the United States.
[…]
Copyright © 2022 Biotech Networks, LLC
